ZHAW Day of Life Sciences 2024: Competencies in Drug Discovery Verified listing

15th Day of Life Sciences hosts Competencies in Drug Discovery, 2nd Edition

The ZHAW invites you to attend  the second edition of its symposium "Competencies in Drug Discovery",  will features a refreshing exchange between the disciplines involved in drug discovery.

The discovery and development of new drugs of medical importance requires the interaction of biological, chemical, and medical expertise. It is precisely this target group that we are addressing with this year’s symposium at our Competence Center for Drug Discovery.

Speakers from industry and universities will provide first-hand, interdisciplinary insights into new therapeutic approaches for various indications and the resulting potential for drug development. Exhibitors will also promote their latest products and a poster session will allow for informal exchange. Both experienced scientists and young researchers will benefit from the wide range of activities at this one-day symposium.

Preliminary Program

• Prof. Dr. Thorsten Buch New avenues towards MS treatments: Targeting the innate immune system Institute of Laboratory Animal Science, University of Zürich, Schlieren, Switzerland
• Dr. Svetlana Diditchenko, Dr. Madlene von Känel-Bohren The long road to a new medicine: the importance of research and development for unleashing the full potential of plasma-derived biotherapeutics CSL Behring, Bern, Switzerland
• Dr. Andreas Dzung Developing copper ionophores as a stress burnout strategy against therapy resistant NRAS melanoma Department of Dermatology, Universitätsspital Zürich, Schlieren, Switzerland
• Prof. Dr. Leo Eberl Biogenesis and applications of bacterial membrane vesicles Department of Plant and Microbial Biology, University of Zurich, Zurich, Switzerland
• PD Dr. Guenter Fritz New lead structures for antibacterials by structure based fragment screening Institute of Biology, University of Hohenheim, Stuttgart, Germany
• Dr. silvia gazzola Opportunities and Challenges in the Development of isoDGR-based Small Molecule-Drug Conjugates for Targeted Tumor Therapy Department of Science and High Technology (DISAT), Università degli Studi dell'Insubria, Como, Italy
• Dr. Arin Ghasparian Fully Synthetic Vaccines – Where do We Stand Shape Biopharmaceuticals Inc., Cambridge, USA Shape Biopharmaceuticals GmbH, Au, Switzerland
• Prof. Dr. Rainer Riedl Competence Center Drug Discovery Institute of Chemistry and Biotechnology, ZHAW Zurich University of Applied Sciences, Wädenswil, Switzerland
• Prof. Dr. Alexander So Manipulating H2S as treatment – Experience of a startup Sulfiscon SA, Lausanne, Switzerland
• Prof. Dr. Douglas C. Woodhams The Amphibian Microbiome and Disease Resilience Department of Biology, UMass Boston, Boston, USA